Cyclical alendronate treatment in postmenopausal women with osteoporosis

Kosus, ACapar, MKosus, N2020-03-262020-03-2620050020-7292https://dx.doi.org/10.1016/j.ijgo.2005.06.026https://hdl.handle.net/20.500.12395/19648[Abstract not Available]en10.1016/j.ijgo.2005.06.026info:eu-repo/semantics/openAccesspostmenopausal osteoporosisalendronateetidronatebone mineral densitybone remodeling markersCyclical alendronate treatment in postmenopausal women with osteoporosisEditorial91218218416098978Q1WOS:000233659800019Q3